Oct 8 (Reuters) - Hemostemix Inc HEM.V :
* Announces brokered private placement
* Says net proceeds from offering will be used to accelerate co's current phase
2 clinical trial involving acp 01
* Private placement offering of up to 5.7 million units at price of $0.70 per
unit
* Source text for Eikon ID:nCCNc8Px4c
* Further company coverage HEM.V